The App, called Mobile MIM, has been available for use in Ireland and the UK by medical professionals since December 11 2010.
With the approval US doctors will be able to assess and make clinical decisions of “computed tomography (CT), magnetic resonance imaging (MRI), and nuclear medicine technology, such as positron emission tomography (PET).”
William Maisel, M.D., M.P.H., chief scientist and deputy director for science in the FDA’s Center for Devices and Radiological Health said, “This important mobile technology provides physicians with the ability to immediately view images and make diagnoses without having to be back at the workstation or wait for film.”
Approval of the App in the States, was delayed while the FDA raised concerns that image resolution, screen glare and contrast issues could interfere with diagnosticians’ ability to properly interpret the images.
The FDA was concerned that the screen brightness and ambient light could mask parts of the image needed for a correct diagnosis. The application was passed thanks to its use of screen brightness controls, significant safety warnings and an on-screen safety guide.
However, the FDA warned that the App is not designed as a replacement of medical workstations but should only be used when access to full medical-viewing equipment is not available.
DARPA is metaphorically manifesting Eris, the Greek goddess of discord and strife, by attempting to…
Since the moment powerful Large Language Models (LLMs) hit the market, the promise of GenAI…
Humanoid robots will be walking and talking among us in the next four or five…
In recent years, fan engagement in sports has transformed from passive viewership into immersive participation.…
Back in 1990, the internet faced a major problem that we don’t regard as relevant…
Today, I’m talking to Prem Ramaswami, the Head of Data Commons at Google. Prem and his team recently…
View Comments